General Mills Inc.

General Mills cereals are getting a drastic update.

It's part of the company's plan to offer a slimmer product line.

The original version sort of created the category before Red Bull, Monster or the concept even existed.

After years of online obsession, a beloved childhood snack finally gives fans what they’ve always wanted.

General Mills has a significant challenge on its hands.

General Mills is flagging a major shift in customer behavior.

Girl Scouts cookies collaborate with an unexpected brand for an exciting new launch.

The chipmaker and Nike top the week's earnings reports

A popular cereal manufacturing company launches a surprising new product with unexpected brands.

A popular cereal manufacturing company makes a shocking announcement amid struggling sales.

Progresso announced a first-of-its-kind soup product, and fans have contradicting feelings about it.

Markets expect the Fed to deliver its third consecutive rate cut later today in Washington but are divided about the central bank's path in 2025.

Regulators have to decide if inflation is still a threat. Wall Street doesn't think so — yet.

A high profile senator is taking aim at a major problem facing shoppers.

TheStreet Pro's Stephen Guilfoyle and stock analysts take a second look at Darden Restaurants.

The food manufacturer is being accused of allegedly allowing white supremacists to run its facility in Georgia.

The popular brand may have made its situation worse with its latest move, and now it has filed for bankruptcy protection.

The nearly 100-year-old ice cream retailer seeks to reorganize in Chapter 11.

Shrinkflation seems to be the latest economic specter dominating headlines and eating into shoppers' budgets, but is it as big of a deal as Biden and the Cookie Monster make it out to be?

These companies can continue their payouts even if the economy turns sharply lower.

My thoughts on today's FOMC presser, Jensen Huang talks GM, and is Google going head-to-head with Amazon Web Services and Azure?

Let's try to make sense of what just happened on Wall Street Friday -- was that a bottom, or what? And a look at what's ahead.

Let's check out where the indicators are as we begin 2025, what happended to 'Santa,' January bounce candidates, and an important to group to watch in the new year.

Let's dive into prices and what they mean -- and don't mean -- for the Fed's rate cut; also, MicroStrategy and Palantir among names slated for Nasdaq 100; and let's chart the markets.

The market didn't do much today! So, let's look at the indicators and look at reader questions.

Here's your roadmap for the day, and also some notes on retail sales, AI, and more.

Not much changed while I was away. The bulls have led in Nasdaq volume and options trading, but the others refuse to rally. We'll also look at XBI, DIS, HON, BBY, and GIS.

The consumer food giant reported a drop in organic sales and the stock charts suggest new lows are ahead.

Tech rules, while the rest of the market drools. Meanwhile, Rivian's venture with VW rekindled my trading enthusiasm after I outsmarted myself in Nvidia.

Think we spend too much on defense? During the Cold War, the U.S. typically spent roughly 5% of GDP on defense. Today, it amounts to just 2.9%.

With some quiet weeks ahead, we'll make sure our portfolio is well positioned for the second half of the year.

Recent chop has given way to chatter about a slowing economy as the industrials, consumers, and commodities take a breather. We also take a look at Palantir, Kellogg, and General Mills.

Folks have gone wild for the Utes, but a shakeout is needed now. Also, let's go bottom fishing with Fastenal, take a peek at the down-and-out JNJ, and examine the biotech ETF.

These reliable names all have yields greater than 3%.

Here's when to trade it.

Though both debt and equity markets strengthened on Tuesday, there was a clear lack of conviction ahead of the FOMC's square dance and hoedown.

Let's harp about the droopy Transports, the lack of a Nasdaq 'whack', and examine some food charts.

There really is only one 'main event' this week. That's the Fed's dog and pony show on Wednesday afternoon.

The investment firm's analysts share their views about the precious metal.

UnitedHealth, still reeling from the murder of one of its top executives, is reportedly facing a Department of Justice investigation.

The federal agency has opted to make a drastic decision during a critical time of the year.